# Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers

> **NCT03774355** · PHASE1 · COMPLETED · sponsor: **CrystalGenomics, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CG1801
- **DRUG:** CGL1802

## Key facts

- **NCT ID:** NCT03774355
- **Lead sponsor:** CrystalGenomics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-17
- **Primary completion:** 2019-05-03
- **Final completion:** 2019-05-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774355, "Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03774355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*